Quarterly Results

ANG LIFESCIENCES INDIA LTD.

NSE : NABSE : 540694ISIN CODE : INE236W01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE45.08-1.75 (-3.74 %)
PREV CLOSE ( ) 46.83
OPEN PRICE ( ) 48.99
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 92879
TODAY'S LOW / HIGH ( )44.49 49.17
52 WK LOW / HIGH ( ) 44.4992.19
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
185.46
332.62
564.62
394.37
Total Expenditure
204.55
316.03
499.15
497.18
PBIDT (Excl OI)
-19.09
16.59
65.47
-102.81
Other Income
-0.29
2.23
3.16
92.33
Operating Profit
-19.39
18.82
68.64
-10.48
Interest
25.14
22.9
23.14
16.54
Exceptional Items
NA
NA
NA
NA
PBDT
-44.53
-4.07
45.5
-27.02
Depreciation
19.14
22.23
21.88
30.26
Profit Before Tax
-63.67
-26.30
23.62
-57.28
Tax
-4.37
-3.14
6.09
-11.2
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-59.3
-23.16
17.53
-46.08
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-59.3
-23.16
17.53
-46.08
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-59.31
-23.17
17.52
-46.09
Equity Capital
130.58
130.58
130.58
130.58
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
-4.54
-1.77
1.34
-3.52
Calculated EPS (Annualised)
-18.16
-7.09
5.36
-14.11
No of Public Share Holdings
NA
3838750
3838750
3838750
% of Public Share Holdings
NA
29.4
29.4
29.4
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-10.29
4.98
11.59
-26.06
PBIDTM%
-10.45
5.65
12.15
-2.65
PBDTM%
-24.01
-1.22
8.05
-6.85
PBTM%
-34.33
-7.90
4.18
-14.52
PATM%
-31.97
-6.96
3.10
-11.68
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.